Form 8-K - Current report:
SEC Accession No. 0000950170-21-005310
Filing Date
2021-12-22
Accepted
2021-12-21 20:00:41
Documents
13
Period of Report
2021-12-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20211221.htm   iXBRL 8-K 52820
2 EX-99.1 allk-ex99_1.htm EX-99.1 43798
  Complete submission text file 0000950170-21-005310.txt   216107

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20211221_lab.xml EX-101.LAB 12798
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20211221_pre.xml EX-101.PRE 9451
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20211221.xsd EX-101.SCH 2484
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-20211221_htm.xml XML 4512
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 211510710
SIC: 2834 Pharmaceutical Preparations